1)Awad IA, Robinson JR:Cavernous malformations and epilepsy, in Awad IA, Barrow DL (eds):Cavernous malformations. AANS Park Ridge, 1993, pp49-64
2)Casey AT, Thomas DG, Harkness WF:Stereotactically-guided craniotomy for cavernous angiomas presenting with epilepsy. Acta Neurochir (Wien) 137:34-37, 1995
3)Chen JS, Ilsen PF:Parieto-occipital arteriovenous malformation. Optometry 73:477-491, 2002
4)Cohen DS, Zubay GP, Goodman RR:Seizure outcome after lesionectomy for cavernous malformations. J Neurosurg 83:237-242, 1995
5)Del Curling O Jr, Kelly DL Jr, Elster AD, Craven TE:An analysis of the natural history of cavernous angiomas. J Neurosurg 75:702-708, 1991
6)Ferrari MD:Sumatriptan in the treatment of migraine. Neurology 43:43-47, 1993
7)Förderreuther S, Henkel A, Noachtar S, Straube A:Headache associated with epileptic seizures;epidemiology and clinical characteristics. Headache 42:649-655, 2002
8)Iwai Y, Yamanaka K, Nakajima H, Miyaura T:Cavernous angioma of the optic chiasma― case report. Neurol Med Chir (Tokyo) 39:617-620, 1999
9)Leão AAP:Spreading depression of activity in the cerebral cortex. J Neurophysiol 7:359-390, 1944
10)Magrotti E, Frascaroli G, Mariani G:Left temporal glioma presenting as migraine with typical aura. Ital J Neurol Sci 13:444, 1992
11)Maruoka N, Yamakawa Y, Shimauchi M:Cavernous hemangioma of the optic nerve. Case report. J Neurosurg 69:292-294, 1988
12)Schon F, Blau JN:Post-epileptic headache and migraine. J Neurol Neurosurg Psychiatry 50:1148-1152, 1987
receptor agonists. Arch Neurol 59:1084-1088, 2002
14)Zevgaridis D, van Velthoven V, Ebeling U, Reulen HJ:Seizure control following surgery in supratentorial cavernous malformations;a retrospective study in 77 patients. Acta Neurochir (Wien) 138:672-677, 1996